Showing results (331-340 of 387) with videos related to
Sort By:
Pageof 39
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2024
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven ApproachConnie Marras, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 18, 2025
Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and RecommendationsRoberta Biundo, Ondrej Bezdicek, Davide Maria Cammisuli, et al.Acta Neuropathologica|April 28, 2018
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathologyErik Portelius, Bob Olsson, Kina Höglund, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2018
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathologyÅsa Sandelius, Erik Portelius, Åsa Källén, et al.Annals of Clinical and Translational Neurology|January 24, 2024
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's diseaseSanaz Arezoumandan, Katheryn A Q Cousins, Daniel T Ohm, et al.Annals of Neurology|March 18, 2026
Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's DiseaseThomas F Tropea, Patricia Aldea Stevenson, Matthew Flitter, et al.NPJ Parkinson'S Disease|June 8, 2024
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson's diseaseAnna Sauerbier, Johanna Herberg, Vasilija Stopic, et al.The American Journal of Psychiatry|January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialLon S Schneider, Constantine Frangakis, Lea T Drye, et al.NPJ Parkinson'S Disease|April 2, 2025
Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson's DiseaseJennifer R Mammen, Jamie L Adams, Rikki Mangrum, et al.Journal of Psychiatric Research|January 7, 2016
Sedation mediates part of Citalopram's effect on agitation in Alzheimer's diseaseJeffery Newell, Jerome A Yesavage, Joy L Taylor, et al.Pageof 39